NEU 0.54% $20.10 neuren pharmaceuticals limited

Ann: DAYBUE (trofinetide) launched in US - Neuren earns US$40m

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.